TREATMENT OPTIONS


 Nerve sparing radical prostatectomy


State-of-the-art external beam radiotherapy


Seed Brachytherapy


Patient Information For High Dose Rate Hdr Prostate Brachytherapy


Hormonal therapy


 Prostatic cryotherapy


Systemic chemotherapy


Radioactive intravenous Strontium


Access to state-of-the-art clinical trial


Patient Information for Radiotherapy


  1. Pain relief for metastatic bone disease


  1. Clinical Trials



Radioactive intravenous Strontium


Strontium, like calcium, is a bone-seeking element when injected. A radio-isotope, Sr89, can be used to treat men when prostate cancer has spread to the bones. Sr89 is an effective way to kill bony metastases, thereby reducing bony pain, fractures and the need for external beam therapy. Side effects are negligible as long as the pre-treatment blood count is satisfactory. Sr89 can be repeated every 6 months, if required.